Common Stock, Shares, Issued of 10x Genomics, Inc. from 31 Dec 2018 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: shares
- Description
- Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
- Summary
-
10x Genomics, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2018 to 31 Dec 2025.
- 10x Genomics, Inc. Common Stock, Shares, Issued for the quarter ending 31 Dec 2025 was 127,691,329, a 4.4% increase year-over-year.
- Source SEC data
- View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)
10x Genomics, Inc. Quarterly Common Stock, Shares, Issued (shares)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 127,691,329 | +5,399,492 | +4.4% | 31 Dec 2025 | 10-K | 13 Feb 2026 | 2025 | FY |
| Q4 2024 | 122,291,837 | +3,196,475 | +2.7% | 31 Dec 2024 | 10-K | 13 Feb 2026 | 2025 | FY |
| Q4 2023 | 119,095,362 | +3,900,353 | +3.4% | 31 Dec 2023 | 10-K | 13 Feb 2025 | 2024 | FY |
| Q4 2022 | 115,195,009 | +2,680,032 | +2.4% | 31 Dec 2022 | 10-K | 15 Feb 2024 | 2023 | FY |
| Q4 2021 | 112,514,977 | +4,029,068 | +3.7% | 31 Dec 2021 | 10-K | 16 Feb 2023 | 2022 | FY |
| Q1 2021 | 109,588,527 | +11,443,319 | +12% | 31 Mar 2021 | 10-Q | 07 May 2021 | 2021 | Q1 |
| Q4 2020 | 108,485,909 | +12,244,313 | +13% | 31 Dec 2020 | 10-K | 18 Feb 2022 | 2021 | FY |
| Q3 2020 | 105,599,976 | +9,481,172 | +9.9% | 30 Sep 2020 | 10-Q | 12 Nov 2020 | 2020 | Q3 |
| Q2 2020 | 100,259,182 | 30 Jun 2020 | 10-Q | 12 Aug 2020 | 2020 | Q2 | ||
| Q1 2020 | 98,145,208 | 31 Mar 2020 | 10-Q | 12 May 2020 | 2020 | Q1 | ||
| Q4 2019 | 96,241,596 | +81,691,795 | +561% | 31 Dec 2019 | 10-K | 26 Feb 2021 | 2020 | FY |
| Q3 2019 | 96,118,804 | 30 Sep 2019 | 10-Q | 12 Nov 2019 | 2019 | Q3 | ||
| Q4 2018 | 14,549,801 | 31 Dec 2018 | 10-K | 27 Feb 2020 | 2019 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.